Successful desensitization to cetuximab in a patient with a positive skin test to cetuximab and specific IgE to alpha-gal

Journal of Investigational Allergology and Clinical Immunology

Volumn 26, Issue 2, 2016, Pages 132-134

  García Menaya, Jesús Miguel ^a   Cordobes Duran C ^a   Gomez Ulla J ^a   Zambonino, M A ^a   Mahecha, A C ^a   Chiarella, G M ^a   Giangrande, N ^a   Bobadilla Gonzalez P ^a  

^a HOSPITAL INFANTA CRISTINA   (Spain)

Author keywords

Alpha gal; Cetuximab; Desensitization; Drug hypersensitivity

Indexed keywords

ALPHA GALACTOSIDASE; ALPHA-GALACTOSIDASE A, HUMAN; ANTINEOPLASTIC AGENT; AUTOANTIBODY; CETUXIMAB; IMMUNOGLOBULIN E;

BLOOD; CARCINOMA, SQUAMOUS CELL; CASE REPORT; DESENSITIZATION; DRUG ADMINISTRATION; DRUG EFFECTS; HUMAN; IMMUNOLOGY; LUNG NEOPLASMS; MALE; MIDDLE AGED; PATHOLOGY; PHARYNGEAL NEOPLASMS; PROCEDURES; PYRIFORM SINUS; SECONDARY; SKIN TEST;

ALPHA-GALACTOSIDASE; ANTINEOPLASTIC AGENTS; AUTOANTIBODIES; CARCINOMA, SQUAMOUS CELL; CETUXIMAB; DESENSITIZATION, IMMUNOLOGIC; DRUG ADMINISTRATION SCHEDULE; HUMANS; IMMUNOGLOBULIN E; LUNG NEOPLASMS; MALE; MIDDLE AGED; PHARYNGEAL NEOPLASMS; PYRIFORM SINUS; SKIN TESTS;

EID: 84964515506     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: 10.18176/jiaci.0031     Document Type: Note

References (10)

1. Galvão VR, Castells MC. Hypersensitivity to biological agentsupdated diagnosis, management, and treatment. J Allergy Clin Immunol Pract. 2015;3:175-85.
2. Chung CH, Mirakhur B, Chan E, Le QT, Berlin J, Morse M, Murphy BA, Satinover SM, Hosen J, Mauro D, Slebos RJ, Zhou Q, Gold D, Hatley T, Hicklin DJ, Platts-Mills TA. Cetuximabinduced anaphylaxis and IgE specific for galactose-alpha-1,3- galactose. N Engl J Med. 2008;358:1109-17.
3. Jerath MR, Kwan M, Kannarkat M, Mirakhur B, Carey L, Valgus J, Platts-Mills TA, Tarrant TK. A desensitization protocol for the mAb cetuximab. J Allergy Clin Immunol. 2009;123:260-2.
4. Saif MW, Syrigos KI, Hotchkiss S, Shanley J, Grasso J, Ferencz TM, Syrigos K, Shah MM. Successful desensitization with cetuximab after an infusion reaction to panitumumab in patients with metastatic colorectal cancer. Cancer Chemother Pharmacol. 2009;65:107-12.
5. Hong DI, Bankova L, Cahill KN, Kyin T, Castells MC. Allergy to monoclonal antibodies: cutting-edge desensitization methods for cutting-edge therapies. Expert Rev Clin Immunol. 2012;8:43-52.
6. Michel S, Scherer K, Heijnen IA, Bircher AJ. Skin prick test and basophil reactivity to cetuximab in patients with IgE to alphagal and allergy to red meat. Allergy. 2014;69: 403-5.
7. Madrigal-Burgaleta R, Berges-Gimeno MP, Angel-Pereira D, Ferreiro-Monteagudo R, Guillen-Ponce C, Pueyo C, Gomez de Salazar E, Alvarez-Cuesta E. Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment. Allergy. 2013;68:853-61.
8. Alvarez-Cuesta E, Madrigal-Burgaleta R, Angel-Pereira D, Ureña-Tavera A, Zamora-Verduga M, Lopez-Gonzalez P, Berges-Gimeno MP. Delving into cornerstones of hypersensitivity to antineoplastic and biological agents: value of diagnostic tools prior to desensitization. Allergy. 2015;70:784-94.
9. Castells MC, Tennant NM, Sloane DE, Hsu FI, Barrett NA, Hong DI, Laidlaw TM, Legere HJ, Nallamshetty SN, Palis RI, Rao JJ, Berlin ST, Campos SM, Matulonis UA. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. J Allergy Clin Immunol. 2008;122:574-80.
10. Dupont B, Mariotte D, Moldovan C, Grellard JM, Vergnaud MC, Laroche D, Gervais R. Case Report About Fatal or Near- Fatal Hypersensitivity Reactions to Cetuximab: Anticetuximab IgE as a Valuable Screening Test. Clin Med Insights Oncol. 2014;8:91-4.